![[The University of Leicester]](unilogo.gif)
Presentations
Cooper NJ, Sutton AJ, Ades AE, Welton NJ. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments for Atrial Fibrillation patients. Cochrane Colloquium, Freiburg, October 2008.
MTC with covariates Cochrane 2008
Cooper NJ, Sutton AJ, Ades AE, Welton NJ. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments for Atrial Fibrillation patients. Society for Research Synthesis Methodology, Corfu, July 2008.
Cooper NJ, Ades AE, Paisley S, Sutton AJ, Longson C, Mugford M, Sculpher M. Use of evidence in economic decision models: Practical issues and methodological challenges. Heath Economists’ Study Group and Collège des Économists de la Santé, London January 2006.
Sutton AJ, Cooper NJ. Methods for synthesising evidence from studies evaluating diagnostic performance of a medical test for economic decision modeling. School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia. November 2005.
Cooper NJ, Coyle D, Abrams KR, Mugford M, Sutton AJ. Use of evidence in economic decision models: an appraisal of health technology assessments in the UK since 1997. Cochrane Colloquium. Melbourne, October 2005.
Cooper NJ, Jones DR, Sutton AJ. Unknown knowns: use of Cochrane review results in designing new studies. Cochrane Colloquium. Melbourne, October 2005.
Cooper NJ, Sutton AJ, Ades AE, Lu G. Evidence synthesis of competing interventions when there is inconsistency in how effectiveness outcomes are measured across studies. Statistics in Healthcare, Joint conference of the Royal Statistical Society (RSS) and Statisticians in the Pharmaceutical Industry (PSI), Cardiff, July 2005.
Cooper NJ, Coyle D, Abrams KR, Mugford M, Sutton AJ. Use of evidence in economic decision models: an application of health technology assessments in the UK since 1997. International Health Economics Association 5th World Congress. Barcelona, July 2005.
Cooper NJ. Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: A Bayesian approach. Part of the Econometric methods for correcting for missing cost and utilization data organized session, International Health Economics Association 5th World Congress, July 2005.
Cooper NJ. Use of evidence in decision models: An appraisal of health technology assessments in the UK. Health Economics Research Centre, University of Oxford, May 2005.
Cooper NJ, Jones DR, Sutton AJ. How is Cochrane evidence used in planning new studies? Department of Health Sciences Christmas conference. Leicester, December 2004.
Cooper NJ. The use of evidence synthesis and uncertainty modelling in economic evidence-based decision models. Centre for Health Economics Research and Evaluation, University of Technology, Sydney, April 2004.
Cooper NJ, Sutton AJ, Abrams KR. Methodology for meta-analysis of mean time to event outcomes in the presence of censoring. Cochrane Colloquium. Barcelona, October 2003.
Time to event data Cochrane 2003
Cooper NJ, Lambert PC, Abrams KR, Sutton AJ. Analysis of repeated measures cost data with zero observations: An application to the costs associated with inflammatory polyarthritis. International Health Economics Association. San Francisco, June 2003.
Cooper NJ, Sutton AJ, Abrams KR, Lambert P. The incorporation of meta-analysis results into evidence based decision modelling. Statistical Advances in Health Technology Assessment. PSI meeting: RSA Durham Street Auditorium, June 2003.
Cooper NJ. The cost of care. British Health Professionals in Rheumatology (BHPR), Keele University, October 2002.
Cooper NJ, Sutton AJ, Abrams KR Lambert P. The incorporation of meta-analysis results into evidence based decision modelling. International Society for Clinical Biostatistics. Dijon, September 2002.
